Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Regeneron inks a $325M deal, selling Asian rights to a pain treatment
Regeneron inks a $325M deal, selling Asian rights to a pain treatment
Regeneron inks a $325M deal, selling Asian rights to a pain treatment
Submitted by
admin
on October 2, 2015 - 4:56pm
Source:
Fierce Biotech
News Tags:
Regeneron
Mitsubishi Tanabe Pharma
musculoskeletal pain
fasinumab
Headline:
Regeneron inks a $325M deal, selling Asian rights to a pain treatment
Do Not Allow Advertisers to Use My Personal information
